Your browser doesn't support javascript.
loading
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
Gross-Goupil, M; Kwon, T G; Eto, M; Ye, D; Miyake, H; Seo, S I; Byun, S-S; Lee, J L; Master, V; Jin, J; DeBenedetto, R; Linke, R; Casey, M; Rosbrook, B; Lechuga, M; Valota, O; Grande, E; Quinn, D I.
Afiliação
  • Gross-Goupil M; Department of Medical Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Kwon TG; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Eto M; Department of Urology, Kyushu University, Fukuoka, Japan.
  • Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Miyake H; Department of Urology, Hamamatsu University, Hamamatsu, Japan.
  • Seo SI; Department of Urology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Byun SS; Department of Urology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Lee JL; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Master V; Department of Urology, Emory University School of Medicine, Atlanta, USA.
  • Jin J; Department of Urology, Peking University First Hospital and Institute of Urology, Beijing, China.
  • DeBenedetto R; SFJ Pharmaceuticals, Inc, Pleasanton, USA.
  • Linke R; SFJ Pharmaceuticals, Inc, Pleasanton, USA.
  • Casey M; Pfizer Inc, Collegeville, USA.
  • Rosbrook B; Pfizer Oncology, San Diego, USA.
  • Lechuga M; Pfizer Srl, Global Product Development, Milan, Italy.
  • Valota O; Pfizer Srl, Global Product Development, Milan, Italy.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
  • Quinn DI; Department of Medical Oncology, USC Keck School of Medicine Norris Comprehensive Cancer Center, Los Angeles, USA. Electronic address: diquinn@med.usc.edu.
Ann Oncol ; 29(12): 2371-2378, 2018 12 01.
Article em En | MEDLINE | ID: mdl-30346481
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Axitinibe / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Axitinibe / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França